An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a new enveloped RNA virus known as Coronavirus (COVID-19) are most prevalent in humans and wild animals. All four species that is alpha, beta, delta and theta have been identified till date and are responsible for human disease; causin...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Journal of Pure and Applied Microbiology
2020-05-01
|
Series: | Journal of Pure and Applied Microbiology |
Subjects: | |
Online Access: | https://microbiologyjournal.org/an-overview-of-novel-coronavirus-sars-cov-2-spanning-around-the-past-present-and-future-perspectives/ |
_version_ | 1811191491061612544 |
---|---|
author | Shadma Yaqoob Areena H. Siddiqui R. Harsvardhan J. Ahmad V.K. Srivastava M.K. Verma P. Verma A.N. Singh |
author_facet | Shadma Yaqoob Areena H. Siddiqui R. Harsvardhan J. Ahmad V.K. Srivastava M.K. Verma P. Verma A.N. Singh |
author_sort | Shadma Yaqoob |
collection | DOAJ |
description | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a new enveloped RNA virus known
as Coronavirus (COVID-19) are most prevalent in humans and wild animals. All four species that is
alpha, beta, delta and theta have been identified till date and are responsible for human disease;
causing influenza like illness (ILI). This virus has similar lineage of Middle East Respiratory Syndrome
coronavirus (MERS-CoV) and related Coronavirus (SARS-CoV). This outbreak initially presented as
pneumonia-like illness in a group of people in Wuhan, China. The infection was said to be caused by
seafood and unusual animals in the wholesale markets of this city. SARS-CoV-2 is highly infectious and
has resulted in a rapid pandemic. As of now it has spread to 197 countries with total no of cases in
the world being 3.76 million as of early march. The mortality till now is 7.11% . The cases have been
increasing since its first discovery in China. In India also the number has been increased. Till now
India has total of 39,980 cases and mortality is attributed to be 3.26%. As per data from Ministry of
health and family welfare (MoHFW) death is more commonly seen in males with age >60years. Among
these most of the deaths were related to other co-morbid conditions. This article will help the readers
with an overview of novel Coronavirus spanning around the clinical features, diagnostic modalities,
treatment strategies and infection control measures. It will also help in raising awareness among
healthcare workers regarding COVID-19 and aid in early recognition of these patients. Moreover, this
review will also focus on the most recent information for the effective management, prevention, and
treatment of patients worldwide. |
first_indexed | 2024-04-11T15:05:47Z |
format | Article |
id | doaj.art-0be37a4bd41f47ae8113b2a1069d1606 |
institution | Directory Open Access Journal |
issn | 0973-7510 2581-690X |
language | English |
last_indexed | 2024-04-11T15:05:47Z |
publishDate | 2020-05-01 |
publisher | Journal of Pure and Applied Microbiology |
record_format | Article |
series | Journal of Pure and Applied Microbiology |
spelling | doaj.art-0be37a4bd41f47ae8113b2a1069d16062022-12-22T04:16:48ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2020-05-0114suppl 177578810.22207/JPAM.14.SPL1.15An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future PerspectivesShadma Yaqoob0Areena H. Siddiqui1https://orcid.org/0000-0002-2524-1711R. Harsvardhan2J. Ahmad3V.K. Srivastava4M.K. Verma5https://orcid.org/0000-0003-2618-4277P. Verma6https://orcid.org/0000-0002-1316-9812A.N. Singh7https://orcid.org/0000-0002-6935-2763Department of Microbiology, Era’s Medical College and Hospital, Lucknow - 226 003, India.Department of Lab Medicine, Sahara Hospital, Lucknow - 226 010, India.Department of Hospital Administration, Sanjay Gandhi Post Graduate Institute, Lucknow - 226 014, India.Department of Pharmacology, BRD Medical College, Gorakhpur - 273 013, India.Lab Director, Cadmus Clinical Laboratories, Lucknow - 226 013, India.Department of Biochemistry, G.S.V.M. Medical College, Kanpur - 208 002, India.Department of Biotechnology, IFTM University, Moradabad - 244 001, India. Department of Biochemistry, G.S.V.M. Medical College, Kanpur - 208 002, India.Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a new enveloped RNA virus known as Coronavirus (COVID-19) are most prevalent in humans and wild animals. All four species that is alpha, beta, delta and theta have been identified till date and are responsible for human disease; causing influenza like illness (ILI). This virus has similar lineage of Middle East Respiratory Syndrome coronavirus (MERS-CoV) and related Coronavirus (SARS-CoV). This outbreak initially presented as pneumonia-like illness in a group of people in Wuhan, China. The infection was said to be caused by seafood and unusual animals in the wholesale markets of this city. SARS-CoV-2 is highly infectious and has resulted in a rapid pandemic. As of now it has spread to 197 countries with total no of cases in the world being 3.76 million as of early march. The mortality till now is 7.11% . The cases have been increasing since its first discovery in China. In India also the number has been increased. Till now India has total of 39,980 cases and mortality is attributed to be 3.26%. As per data from Ministry of health and family welfare (MoHFW) death is more commonly seen in males with age >60years. Among these most of the deaths were related to other co-morbid conditions. This article will help the readers with an overview of novel Coronavirus spanning around the clinical features, diagnostic modalities, treatment strategies and infection control measures. It will also help in raising awareness among healthcare workers regarding COVID-19 and aid in early recognition of these patients. Moreover, this review will also focus on the most recent information for the effective management, prevention, and treatment of patients worldwide.https://microbiologyjournal.org/an-overview-of-novel-coronavirus-sars-cov-2-spanning-around-the-past-present-and-future-perspectives/covid-19pandemicimmunoinformaticsmers covresiliencesars cov-2 |
spellingShingle | Shadma Yaqoob Areena H. Siddiqui R. Harsvardhan J. Ahmad V.K. Srivastava M.K. Verma P. Verma A.N. Singh An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives Journal of Pure and Applied Microbiology covid-19 pandemic immunoinformatics mers cov resilience sars cov-2 |
title | An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives |
title_full | An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives |
title_fullStr | An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives |
title_full_unstemmed | An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives |
title_short | An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives |
title_sort | overview of novel coronavirus sars cov 2 spanning around the past present and future perspectives |
topic | covid-19 pandemic immunoinformatics mers cov resilience sars cov-2 |
url | https://microbiologyjournal.org/an-overview-of-novel-coronavirus-sars-cov-2-spanning-around-the-past-present-and-future-perspectives/ |
work_keys_str_mv | AT shadmayaqoob anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT areenahsiddiqui anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT rharsvardhan anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT jahmad anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT vksrivastava anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT mkverma anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT pverma anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT ansingh anoverviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT shadmayaqoob overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT areenahsiddiqui overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT rharsvardhan overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT jahmad overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT vksrivastava overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT mkverma overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT pverma overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives AT ansingh overviewofnovelcoronavirussarscov2spanningaroundthepastpresentandfutureperspectives |